Marker Therapeutics, Inc.
NASDAQ:MRKR
2.54 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.311 | 9.005 | 1.242 | 0.467 | 0.213 | 0.206 | 0.183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.025 | 0.121 |
| Cost of Revenue
| 10.417 | 3.68 | 3.163 | 18.881 | 12.765 | 123.998 | 5.251 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.039 |
| Gross Profit
| -7.106 | 5.324 | -1.921 | -18.414 | -12.552 | -123.792 | -5.068 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.022 | 0.082 |
| Gross Profit Ratio
| -2.146 | 0.591 | -1.547 | -39.448 | -58.874 | -600.948 | -27.684 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.895 | 0.68 |
| Reseach & Development Expenses
| 10.417 | 26.139 | 27.795 | 18.881 | 12.765 | 123.998 | 5.251 | 3.8 | 1.711 | 0.189 | 0.662 | 1.057 | 0.204 | 0.29 | 0.093 | 0.182 | 0.426 | 0.173 | 0.248 | 1.039 | 1.727 | 0.834 | 0 | 0.341 | 0.295 |
| General & Administrative Expenses
| 7.476 | 12.82 | 12.925 | 10.472 | 9.977 | 24.38 | 6.412 | 4.692 | 4.448 | 3.182 | 2.003 | 4.42 | 2.433 | 3.651 | 4.097 | 1.311 | 2.08 | 0.709 | 0.594 | 1.607 | 4.01 | 1.41 | 0.38 | 1.128 | 0.834 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.476 | 12.82 | 12.925 | 10.472 | 9.977 | 24.38 | 6.412 | 4.692 | 4.448 | 3.182 | 2.003 | 4.42 | 2.433 | 3.651 | 4.097 | 1.311 | 2.08 | 0.709 | 0.594 | 1.607 | 4.01 | 1.41 | 0.38 | 1.128 | 0.834 |
| Other Expenses
| -10.417 | -0.233 | -2.407 | 0 | 0 | 116.045 | -0.183 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0.004 | 0.007 | 0.006 | 0.006 | 0.148 | 0.037 | 0.042 | 0.041 | 0 | 0.021 | 0.018 |
| Operating Expenses
| 7.476 | 38.959 | 40.72 | 29.353 | 22.742 | 148.378 | 11.48 | 8.261 | 6.159 | 3.371 | 2.664 | 5.478 | 2.637 | 3.942 | 4.193 | 1.5 | 2.511 | 0.888 | 0.99 | 2.683 | 5.779 | 2.285 | 0.38 | 1.49 | 1.147 |
| Operating Income
| -14.581 | -29.946 | -39.478 | -28.886 | -22.529 | -148.172 | -11.663 | -8.492 | -6.159 | -3.371 | -3.31 | -6.223 | -2.637 | -3.942 | -5.382 | -2.279 | -2.511 | -0.888 | -0.99 | -2.683 | -5.779 | -2.285 | -0.38 | -1.467 | -1.065 |
| Operating Income Ratio
| -4.404 | -3.326 | -31.793 | -61.882 | -105.673 | -719.301 | -63.711 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -58.576 | -8.819 |
| Total Other Income Expenses Net
| 0.539 | 0.015 | -2.401 | 0.18 | 1.101 | 0.214 | 0.498 | 6.037 | -27.907 | -27.512 | -2.868 | -0.374 | 0.608 | -1.149 | -0.269 | -0.696 | -1.38 | -0.416 | 0.03 | 0 | 0 | 0 | -0.005 | 0.461 | -0.063 |
| Income Before Tax
| -14.042 | -29.931 | -41.879 | -28.706 | -21.428 | -147.958 | -10.982 | -2.455 | -34.066 | -30.883 | -5.533 | -5.858 | -2.029 | -5.091 | -4.462 | -2.196 | -3.891 | -1.304 | -0.99 | -2.683 | -5.779 | -2.285 | -0.385 | -1.292 | -1.127 |
| Income Before Tax Ratio
| -4.241 | -3.324 | -33.727 | -61.497 | -100.509 | -718.263 | -59.991 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51.568 | -9.339 |
| Income Tax Expense
| 0.004 | -0.015 | -0.006 | -0.18 | -1.101 | -0.214 | -0.681 | -6.037 | 27.897 | 26.937 | 0.466 | -1.11 | -1.287 | -0.094 | 4.462 | 2.196 | 3.891 | 1.304 | 0.99 | 2.683 | 5.779 | 2.285 | 0.385 | 1.292 | 1.127 |
| Net Income
| -14.046 | -29.916 | -41.873 | -28.526 | -20.327 | -147.958 | -10.982 | -2.455 | -34.066 | -30.883 | -5.533 | -5.858 | -2.029 | -5.091 | -4.462 | -2.196 | -3.891 | -1.304 | -0.99 | -2.683 | -5.779 | -2.285 | -0.385 | -1.292 | -1.127 |
| Net Income Ratio
| -4.242 | -3.322 | -33.722 | -61.112 | -95.346 | -718.263 | -59.991 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51.568 | -9.339 |
| EPS
| -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.5 | -11.62 | -3.56 | -93.02 | -239.63 | -584.4 | -1,072.88 | -529.47 | -1,535.18 | -1,396.11 | -1,124.39 | -2,244.18 | -1,304,387 | -989,558 | -2,683,105 | -5,778,905 | -2,284,709 | -384,540 | -1,291,831 | -1,127,327 |
| EPS Diluted
| -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.5 | -11.62 | -3.31 | -93.02 | -239.63 | -584.4 | -1,072.88 | -529.47 | -1,535.18 | -1,396.11 | -1,124.39 | -2,244.18 | -1,304,387 | -989,558 | -2,683,105 | -5,778,905 | -2,284,709 | -384,540 | -1,291,831 | -1,127,327 |
| EBITDA
| -11.792 | -19.791 | -36.315 | -27.63 | -22.029 | -147.966 | -11.297 | 6.037 | -34.055 | -30.308 | -3.776 | -5.582 | 0 | -3.85 | -3.269 | -1.41 | -2.505 | -0.851 | -0.838 | -2.646 | -5.737 | -2.244 | -0.38 | -0.457 | -1.047 |
| EBITDA Ratio
| -3.561 | -2.917 | -29.246 | -59.644 | -104.413 | -719.107 | -65.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -64.761 | -8.152 |